跳至主要内容
临床试验/CTRI/2017/12/011006
CTRI/2017/12/011006尚未招募2 期

A Clinical Study to Evaluate the Efficacy and Safety of Tukhm-i Kahu in the Management of Zaght al-Dam Qawi Lazimi (Essential Hypertension)

Central Research Institute of Unani Medicine0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All subjects will meet the following criteria:
  • 1-Patients of any sex in the age group of 35 to 55 years
  • 2-Patients having Stage-I Hypertension according to JNC-8 (Systolic BP 140-159 and
  • Diastolic BP 90-99 mmHg) with or without the following symptoms:
  • 3-Suda (Headache)
  • 4-Khafaqan (Palpitation)
  • 5-Kasal (Laziness)
  • 6-Qalaq (Anxiety)
  • 7-Usr al-Tanaffus (Breathlessness)
  • 8-Nabz Mumtali (Pulsus plenus)
  • 9-Clinically stable patients
  • 10-Patients not taking any anti-hypertensive drugs
  • 11-Patients willing to sign the informed consent form

排除标准

  • Patients will be excluded if they meet any of the following criteria:
  • 1-Patient with SBP >=160 mmHg and DBP >=100 mmHg
  • 2-Patients of Secondary Hypertension
  • 3-Pregnant and Lactating women
  • 4-Obese subjects â?? BMI >30
  • 5-Drug Addicts, Alcoholics
  • 6-Patients not willing to give consent
  • 7-Patients not willing to come for follow-up

研究者

相似试验